Health
Putting the ‘STING’ on CAR-T cells to turn them against breast cancer and other solid tumors – FierceBiotech
Activating the immune pathway STING creates an inflammatory environment that should improve immuno-oncology treatments, but clinical trials have been disappointing…
The immune pathway known as stimulator of interferon genes (STING) has long been of interest in the oncology community because activating it creates an inflammatory environment that should improve the ability of immune cells to attack cancer. But experimental STING-activating treatments have produced mixed results in clinical trials.
Researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have promising evidence that adding STING activators to CAR-T cell therapies…
-
Business17 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoYoung voices shape Sunshine Coast’s future
-
Noosa News14 hours agoSudden death investigation, Maroochydore – Sunshine Coast
-
General21 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’